Pharmacotherapy for hyperuricaemia in hypertensive patients
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Pharmacotherapy for Hyperuricaemia in Hypertensive Patients." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/436251/all/Pharmacotherapy_for_hyperuricaemia_in_hypertensive_patients.
Pharmacotherapy for hyperuricaemia in hypertensive patients. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436251/all/Pharmacotherapy_for_hyperuricaemia_in_hypertensive_patients. Accessed February 5, 2025.
Pharmacotherapy for hyperuricaemia in hypertensive patients. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436251/all/Pharmacotherapy_for_hyperuricaemia_in_hypertensive_patients
Pharmacotherapy for Hyperuricaemia in Hypertensive Patients [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 February 05]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/436251/all/Pharmacotherapy_for_hyperuricaemia_in_hypertensive_patients.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Pharmacotherapy for hyperuricaemia in hypertensive patients
ID - 436251
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/436251/all/Pharmacotherapy_for_hyperuricaemia_in_hypertensive_patients
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -